Global Digital Therapeutics Market Size, Share, and COVID-19 Impact Analysis, By Type (Devices, Software & Services), By Application(Prevention (Prediabetes, Obesity, Others), Treatment (Diabetes, Respiratory Care, Mental Health, Cardiovascular, and Others)), By Sales Channel ((Business to Consumer (B2C) (Caregiver and Patient), Business to Business (B2B) (Healthcare Provider, Employer, and Others)), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033

Industry: Healthcare


Global Digital Therapeutics Market Insights Forecasts to 2033

  • The Global Digital Therapeutics Market Size was Valued at USD 6.08 Billion in 2023
  • The Market Size is Growing at a CAGR of 28.23% from 2023 to 2033
  • The Worldwide Digital Therapeutics Market  Size is Expected to Reach USD 73.09 Billion by 2033
  • Asia Pacific is Expected to Grow the fastest during the forecast period.


Get more details on this report -

Request Free Sample PDF


The Digital Therapeutics Market Size is Anticipated to Exceed USD 73.09 Billion by 2033, Growing at a CAGR of 28.23% from 2023 to 2033.


Market Overview

Software driven evidence based treatments for the prevention, management, or treatment of diseases or medical disorders are known as digital therapeutics or DTx. DTx is a subset of digital health that uses clinically tested, evidence-based software to administer therapeutic interventions directly to patients.  The increased demand for these products is also due to the increasing prevalence of chronic diseases such as diabetes, mental illness, cancer, and heart failure (HF), worldwide. Hence, the adoption of therapeutics for managing and treating various chronic illnesses is increasing among patients. Digital therapeutics help in tracking daily activities, managing diet and lifestyle, prescribing customized medications, and treating mental, behavioral, and physical health issues. Innovative and technologically sophisticated therapies reduce human error, boost customer happiness, offer data based insights to their clients, and deliver a superior user experience all of which drive up demand for these therapies in the marketplace. The market is anticipated to grow as a result of the top companies growing focus on creating highly advanced software that is simple for doctors and patients to access. Analysis has indicated that the use of digital medicines in the management of chronic illnesses can improve patient outcomes. As a result, this is propelling the market's growth.


Report Coverage

This research report categorizes the market for the digital therapeutics market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the digital therapeutics market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the digital therapeutics market.


Global Digital Therapeutics Market Report Coverage

Report CoverageDetails
Base Year:2023
Market Size in 2023:USD 6.08 Billion
Forecast Period:2023 to 2033
Forecast Period CAGR 2023 to 2033 :28.23%
2033 Value Projection:USD 73.09
Historical Data for:2019-2022
No. of Pages:233
Tables, Charts & Figures:115
Segments covered:By Type, By Application, By Sales Channel, Region and COVID-19 Impact Analysis
Companies covered:: LifeScan Inc., Teladoc Health, Omada Health Inc., Pear Therapeutics, Inc., Mango Health, Limbix Health, Inc., Voluntis, Inc., Canary Health Inc., Otsuka Holdings Co., Ltd, Livongo Health Inc.,, DarioHealth Corp., Akili Interactive Labs, Inc., Gsk Digital Therapeutics, Welldoc, Inc., and others Key players.
Pitfalls & Challenges:COVID-19 Empact, Challenges, Future, Growth, & Analysis

Get more details on this report -

Request Free Sample PDF

Driving Factors

Digital therapy is used to provide the patients with evidence based treatment solutions. Through the use of hardware and software, medical diseases can be managed, prevented, or treated. The digital therapeutics software can be used either independently or in combination with other therapies to deliver patient care and health outcomes. The increasing need for the management and treatment of chronic illnesses is driving the use of therapeutics software and devices. There is a growing need for more reasonably priced treatment choices as healthcare costs grow. Digital treatments are a cost effective substitute for treatment techniques, which can be demanding and can involve multiple medical visits.


Restraining Factors

The digital therapeutics market is a developing area of device and software driven medical condition management and prevention devices. However, a key challenge preventing the widespread use of medicines is the escalating cybersecurity problems. Information security and privacy are becoming more and more increasing as a result of the rising number of data thefts, breaches, and leaks. Fraudulent attacks on sensitive patient data and data privacy cases are increasing at the moment.


Market Segmentation

The digital therapeutics market share is classified into type, application, and sales channel.


  • The software & services segment is expected to account for the largest revenue share through the forecast period.

Based on the type, the digital therapeutics market is categorized into devices, software & services. Among these, the software & services segment is expected to account for the largest revenue share through the forecast period. The reason propelling the growth of the software and services market is the growing need to reduce healthcare facility costs worldwide and the incorporation of cutting edge technologies like artificial intelligence (AI) and machine learning (ML) in digital therapeutic apps. The demand for this software and services has increased as a result of expanding initiatives by different healthcare organizations and industry participants, such as raising awareness about the prevention and treatment of chronic illnesses.


  • The treatment (diabetes, respiratory care, mental health, cardiovascular) segment dominates the market with the largest market share through the forecast period.

Based on the application, the digital therapeutics market is categorized into preventive (prediabetes, obesity, and others), treatment (diabetes, respiratory care, mental health, cardiovascular), and others. Among these, the treatment (diabetes, respiratory care, mental health, cardiovascular) segment dominates the market with the largest market share through the forecast period. Patients can easily access their medication while experiencing convenient usability due to the software. The market's development would be helped by market participants' increased focus on developing software for patients with chronic illnesses like diabetes, mental health issues, and cardiovascular disorders.


  • The business to customer is anticipated to grow at the highest CAGR growth through the forecast period.

Based on the sales channel, the digital therapeutics market is categorized into business to consumer (B2C) (caregiver and patient), business to business (B2B) (healthcare provider, employer, and others), and others. Among these, the business to customer is anticipated to grow at the highest CAGR growth through the forecast period. Due to patients and caregivers raising awareness of the advantages and use of these products. Demand for these therapeutics apps is predicted to rise due to factors such as rising health consciousness and self-management trends among individuals, expanding smartphone penetration and internet connectivity enabling direct-to-consumer delivery models, and growing consumer demand for easy to access healthcare solutions.


Regional Segment Analysis of the Digital Therapeutics Market

  • North America (U.S., Canada, Mexico) 
  • Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Rest of APAC)
  • South America (Brazil and the Rest of South America) 
  • The Middle East and Africa (UAE, South Africa, Rest of MEA)


North America is anticipated to hold the largest share of the digital therapeutics market over the predicted timeframe.

Global Digital Therapeutics Market

Get more details on this report -

Request Free Sample PDF

North America is projected to hold the largest share of the digital therapeutics market over the forecast period. Increased investments in digital therapeutics, changes to the reimbursement system for these treatments, an increase in the number of new companies in the digital therapeutics space, and government programs supporting technological advancements in the region are the main causes of the accelerated growth in North America. Over the course of the projection period, the region's overall market is anticipated to rise significantly due to attractive reimbursement scenarios that emphasize better tracking and diagnosis as well as enhanced quality of life through higher use of digital health products. Furthermore, profitable expansion is anticipated as a result of strategic activities carried out by major businesses in this region, like mergers and acquisitions and the introduction of new products.


Asia Pacific is expected to grow at the fastest CAGR growth of the digital therapeutics market during the forecast period. Due to the growing government expenditure on healthcare and the strong demand for IT services. Additionally, as these systems make it possible for hospitals to handle their clinical, financial, and administrative components more effectively, demand for healthcare IT systems has been rising. The fundamental drivers driving the rapid growth of the digital therapeutics business in Asia Pacific are rising smartphone usage, rising healthcare costs, and better Internet connectivity.


Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the digital therapeutics market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.


List of Key Companies

  • LifeScan Inc.
  • Teladoc Health
  • Omada Health Inc.
  • Pear Therapeutics, Inc.
  • Mango Health
  • Limbix Health, Inc.
  • Voluntis, Inc.
  • Canary Health Inc.
  • Otsuka Holdings Co., Ltd
  • Livongo Health Inc., 
  • DarioHealth Corp.
  • Akili Interactive Labs, Inc.
  • Gsk Digital Therapeutics
  • Welldoc, Inc.
  • Others


Key Target Audience

  • Market Players
  • Investors
  • End-users
  • Government Authorities 
  • Consulting And Research Firm
  • Venture capitalists
  • Value-Added Resellers (VARs)


Recent Developments

  • In August 2023, The FDA has approved Welldoc, Inc.'s BlueStar diabetes digital health solution for the tenth time.
  • In October 2023, AspyreRx is the first cognitive behavioral therapy (CBT) app designed specifically for treating people with type 2 diabetes (T2D). Better Therapeutics, Inc. announced its commercial debut.


Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global digital therapeutics market based on the below-mentioned segments: 


Global Digital Therapeutics Market, By Type

  • Devices
  • Software & Services


Global Digital Therapeutics Market, By Application

  • Preventive
  • Prediabetes
  • Obesity
  • Others
  • Treatment
  • Diabetes
  • Respiratory Care
  • Mental Health
  • Cardiovascular
  • Others


Global Digital Therapeutics Market, By Sales Channel

  • Business-to-Consumer (B2C)
    • Caregiver
    • Patient
  • Business-to-Business (B2B)
    • Healthcare Provider
    • Employer
    • Others


Global Digital Therapeutics Market, By Regional Analysis

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Qatar
    • South Africa
    • Rest of the Middle East & Africa

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies